# Yantai Luye Pharmaceutical Holdings

Yantai Luye Pharmaceutical Holdings is a Corporate Investor based in Yantai, China.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Yantai, China
- **Region:** Asia
- **Address:** Yantai, Shandong, China
- **Founded:** 1994
- **Assets under management:** Undisclosed
- **Website:** luye.com
- **LinkedIn:** https://www.linkedin.com/company/luye-pharmacy-group

## Regulatory record

- **Reports private funds:** No

## About

Yantai Luye Pharmaceutical Holdings (Group) is a corporate investor based in Yantai, China. It manages approximately $3.9 billion in assets across two funds, primarily focused on Asia.

## Sectors

- Healthcare Services
- Real Estate
- Luxury

## Offices

- Shanghai, China
- Shenzhen, China

## People

- Liu Dianbo — Executive Chairman and Founder, Luye Life Sciences Group
- Yuan Huixian — Executive Director and Founding Member
- Yang Rongbing — Vice Executive Chairman and Founding Member

## Questions

### Who controls investment decisions at Yantai Luye Pharmaceutical Holdings?

Strategic and investment decisions are concentrated with founder and Executive Chairman Liu Dianbo, alongside founding members Yuan Huixian and Yang Rongbing. The group operates as a closely held corporate investor with no external limited partners, meaning the founding trio controls both the pharmaceutical operating business and the allocation of its cash flows into real estate, healthcare infrastructure, and other assets.

### How does the holding group relate to the publicly traded Luye Pharma Group?

Yantai Luye Pharmaceutical Holdings is the private parent and controlling shareholder of Luye Pharma Group, which listed on the Hong Kong Stock Exchange in 2014. The holding company retains the pharmaceutical dividends and directs them into private investments, while Luye Pharma remains the core operating business with manufacturing plants across China and international licensing partnerships, including with AstraZeneca.

### What does the group's real estate portfolio consist of?

The portfolio is concentrated in Yantai, Shandong province, and includes Pula Valley, a mixed-use winery and chateau development, and Jiaodong Culture Square, a commercial complex that houses a theater and Yantai Urban Art Gallery. The group also holds commercial assets in Shanghai and Shenzhen tied to its healthcare operations, and the Pula Valley wine collection represents an additional investment in luxury hospitality and lifestyle.

### What is the nature of the collaboration with Cleveland Clinic?

The group is developing the Shanghai New Hongqiao International Medical Center in partnership with Cleveland Clinic, one of the most recognized US hospital brands. This represents a major capital commitment to premium private healthcare delivery in China, leveraging Cleveland Clinic's clinical protocols and brand while Yantai Luye provides the real estate and local operating infrastructure.

## Related profiles

- [Yantai Jereh Oilfield Services Group](https://altss.com/profile/yantai-jereh-oilfield-services-group)
- [Yara Growth Ventures](https://altss.com/profile/yara-growth-ventures)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/yantai-luye-pharmaceutical-holdings-group

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology